Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 6.4
-4.19 %
$ 236 M
Market Cap
49.23
P/E
Price Target
Average
1.56%
Revenue Forecast
Estimate
7.19%
EBIT
Estimate
--42.92%
Net Income
Estimate
--40.85%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Lifecore Biomedical, Inc.
Wall Street analysts predict an average 1-year price target for LFCR of $6.5 , with forecasts ranging from a low of $5 to a high of $8 .
LFCR Lowest Price Target
Wall Street Target
5 USD
-21.88%
LFCR Average Price Target
Wall Street Target
6.5 USD
1.56%
LFCR Highest Price Target
Wall Street Target
8 USD
25.00%
REVENUE FORECAST
Revenue Forecast Chart LFCR
EBIT FORECAST
EBIT Forecast Chart LFCR
NET INCOME FORECAST
Net Income Chart LFCR